Bangladesh's transformation is genuinely one of the great development stories of the past three decades: GDP growth averaging around 6% annually since 2000, manufacturing's share of GDP more than doubling since 1980, and agriculture's share falling from roughly 60% of the economy in 1971 to about 10% today. Nominal GDP has grown from $6.29 billion in 1972 to well over $400 billion today. Almost none of that was accidental — it was built, deliberately, on a single export engine.
That engine is ready-made garments. Bangladesh is the world's second-largest apparel exporter after China, and RMG alone accounts for roughly 81% of the country's total exports — a concentration this letter series has flagged as a genuine structural risk in every profile that carries it, and Bangladesh carries it more than any other market covered here.
The Garment EngineGarment exports reached a record $47.1 billion in 2024, up from just $6.6 billion in 2000 — a genuinely extraordinary run. Bangladesh now holds roughly 7% of the global apparel market, sourcing to nearly every major Western fast-fashion brand on competitive labour costs and, notably, the highest number of certified green garment factories of any country in the world as of 2024. The honest complication arrives on a fixed date: Bangladesh is scheduled to graduate from Least Developed Country (LDC) status on November 24, 2026 — a genuine milestone of development success that simultaneously phases out the preferential trade access (including the EU's Everything But Arms scheme) that helped build the garment sector in the first place. A transition period is expected to soften the landing, but the structural question — what replaces LDC-era trade preferences — remains open.
Bangladesh's largest pharmaceutical company, direct exposure to a sector growing roughly 12% annually and now supplying 98% of domestic medicine demand — one of the only LDCs in the world close to pharmaceutical self-sufficiency.
A diversified conglomerate spanning textiles, pharmaceuticals, and ceramics — one of the more direct listed-equity ways to gain exposure across Bangladesh's industrial base rather than garments alone.
The most underappreciated stabiliser in Bangladesh's economy isn't a sector at all — it's the diaspora. Remittances from Bangladeshi workers abroad remain a vital, genuinely reliable source of foreign exchange, and reserve rebuilding through 2026 has been described as real, credible progress even as other parts of the economy remain under stress. Pharmaceuticals stand out as the clearest candidate for a genuine second export engine: growing at roughly 12% annually, with local firms meeting 98% of domestic medicine demand, an unusually strong position for a country at Bangladesh's income level. Industry overall now represents roughly 34-38% of GDP, up meaningfully from 1980 levels, evidence the diversification push is real even if garments still dominate the headline numbers.
The Dhaka Stock Exchange (DSE) is a genuine, functioning market, but the banking sector sits under real stress: non-performing loans around 24% of the loan book, and private-sector credit growth slowing to roughly 6.6% even as public borrowing accelerates past 23% — a sign the financial system is currently better at financing government deficits than private investment. Political disruption from the July 2024 uprising and the subsequent transition have added a genuine layer of uncertainty institutions are still pricing in.
The institutional forecasts for 2026 disagree meaningfully with each other — the World Bank near 3.9%, the IMF near 4.7%, the ADB's own April 2026 outlook at 3.7% — a wider spread than usual, reflecting real uncertainty about how fast the post-2024 economy actually recovers. What isn't in dispute: FY2024-25 growth of roughly 3.5% was the slowest in years, well below the historical ~6% trend, driven by political disruption, banking-sector stress, energy shortages, and cautious private investment. Inflation near 9% and a double-digit NPL ratio are real, current constraints, not historical footnotes.
LDC graduation in November 2026 is being managed with a transition period, but it is still the single clearest deadline in this entire letter series — a fixed date on which the trade architecture that built Bangladesh's growth story begins to change. Whether pharmaceuticals, remittances, and industrial diversification are far enough along to absorb that shift is the one number worth tracking above all others here.
This reads as a long-horizon structural position on whether Bangladesh successfully broadens its export base beyond garments — not a near-term cyclical trade, given the current banking stress and political transition still working through the system. The pharmaceutical sector specifically is the name worth watching for evidence the diversification argument is real rather than aspirational.
Bangladesh is one of the genuine development success stories of the last three decades, and its garment industry remains a formidable, well-earned export machine. But this profile carries the single most concentrated export exposure in this entire letter series — 81% in one sector — at the exact moment the trade preferences that helped build it begin to expire. Pharmaceuticals and remittances are real, credible signs of diversification already underway; whether they're far enough along before LDC graduation fully bites is the honest open question. This is a market to watch closely through 2026-2027, not one to size heavily today.